Kento Fukano - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Kento Fukano

Showing results (21-30 of 24) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 24 results.

Journal of Hepatology|November 29, 2016

Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activitySatomi Shimura, Koichi Watashi, Kento Fukano, et al.

Scientific Reports|November 28, 2020

MCPIP1 reduces HBV-RNA by targeting its epsilon structureYingfang Li, Lusheng Que, Kento Fukano, et al.

Biochemical and Biophysical Research Communications|June 15, 2021

Identification of natural compounds extracted from crude drugs as novel inhibitors of hepatitis C virusXin Zheng, Rui Guo, Qingbo Liu, et al.

Scientific Reports|February 11, 2018

Chemical array system, a platform to identify novel hepatitis B virus entry inhibitors targeting sodium taurocholate cotransporting polypeptideManabu Kaneko, Yushi Futamura, Senko Tsukuda, et al.

Pageof 3

Search research articles

Showing results (21-30 of 24) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 24 results.

Journal of Hepatology|November 29, 2016

Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activitySatomi Shimura, Koichi Watashi, Kento Fukano, et al.

Scientific Reports|November 28, 2020

MCPIP1 reduces HBV-RNA by targeting its epsilon structureYingfang Li, Lusheng Que, Kento Fukano, et al.

Biochemical and Biophysical Research Communications|June 15, 2021

Identification of natural compounds extracted from crude drugs as novel inhibitors of hepatitis C virusXin Zheng, Rui Guo, Qingbo Liu, et al.

Scientific Reports|February 11, 2018

Chemical array system, a platform to identify novel hepatitis B virus entry inhibitors targeting sodium taurocholate cotransporting polypeptideManabu Kaneko, Yushi Futamura, Senko Tsukuda, et al.

Pageof 3